Search

everythinglearnresearchcommunity

for

Search:↓

Sunlight simulation causes skin inflammation, with different skin types reacting at different levels of exposure.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Stem cell treatments led to complete hair regrowth in a 40-year-old man.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

Some people with severe hair loss saw hair regrowth after a specific light and drug treatment.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Hibiscus leaf extract is better for diabetes, and Eclipta alba bark extract is better for antioxidants.

The botanical treatment for hair loss shows promise, especially for children.

The plant extract helped increase hair growth in men without severe side effects.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Platelet-rich plasma is more effective and satisfactory than hyaluronic acid for knee osteoarthritis.

Current treatments for alopecia show no significant long-term benefits.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

1% minoxidil didn't improve hair growth in severe alopecia areata.

UK stem-cell clinics often mislead about treatment safety and effectiveness, needing better regulation.

Upadacitinib effectively treats severe alopecia areata and is safe.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

UVFD helps detect hair follicles in alopecia areata better than traditional methods.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

The prototype for analyzing skin aging works technically and clinically.